.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Chubb
McKesson
Medtronic
Harvard Business School
Healthtrust
Mallinckrodt
Cipla
Covington
UBS

Generated: June 25, 2017

DrugPatentWatch Database Preview

GLYCOLAX Drug Profile

« Back to Dashboard

What is the patent landscape for Glycolax, and what generic Glycolax alternatives are available?

Glycolax is a drug marketed by Kremers Urban Pharms and is included in two NDAs.

The generic ingredient in GLYCOLAX is polyethylene glycol 3350. There are four hundred and seventeen drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.

Summary for Tradename: GLYCOLAX

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list5
Clinical Trials: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GLYCOLAX at DailyMed

Pharmacology for Tradename: GLYCOLAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kremers Urban Pharms
GLYCOLAX
polyethylene glycol 3350
FOR SOLUTION;ORAL090600-001Oct 6, 2009OTCNoNo► Subscribe► Subscribe
Kremers Urban Pharms
GLYCOLAX
polyethylene glycol 3350
FOR SOLUTION;ORAL090600-002Oct 6, 2009OTCNoNo► Subscribe► Subscribe
Kremers Urban Pharms
GLYCOLAX
polyethylene glycol 3350
FOR SOLUTION;ORAL076652-001Jul 2, 2004AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cipla
Novartis
Johnson and Johnson
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
Citi
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot